ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Celgene Corporation


Include trials that are no longer recruiting patients.

10 studies were found.
1.RecruitingCC-5013 in Myelofibrosis
Condition: Myelofibrosis
2.RecruitingCombination Bisphosphonate and Anti-Angiogenesis Therapy with Pamidronate and Thalidomide
Condition: Multiple Myeloma
3.RecruitingCombination Bisphosphonate and Anti-Angiogenesis Therapy with Pamidronate and Thalidomide
Condition: Multiple Myeloma
4.RecruitingA Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
Condition: Multiple Myeloma
5.RecruitingPhase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas
Conditions: Glioblastoma; Malignant Gliomas
6.RecruitingStudy of Combination PS-341 and Thalidomide in Multiple Myeloma
Condition: Multiple Myeloma
7.RecruitingStudy of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple Myeloma
Condition: Multiple Myeloma
8.Not yet recruitingStudy of MAGE-A3 and NY-ESO-1 Immunotherapy in Combination with DTPACE Chemotherapy and Autologous Transplantation in Multiple Myeloma
Condition: Multiple Myeloma
9.RecruitingStudy of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
Condition: Multiple Myeloma
10.RecruitingUARK 2003-33, Total Therapy III
Condition: Multiple Myeloma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act